Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069732 · ClinicalTrials.gov registry record · Phase 2
Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss
A Phase 2 study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT00069732: Clinical Trial Phase 2 study, sponsored by Kaiser Permanente.
NCT00069732 is a Phase 2 study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 90 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00069732, a Phase 2 study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
The goal of this study is to pilot test in a group of overweight-obese individuals the feasibility and acceptability and indications of efficacy of two CAM treatments, qigong, and acupressure-TAT, for improving long term maintenance of weight loss.
Interventions
- BEHAVIORAL qigong
- BEHAVIORAL acupressure-TAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Phase | Phase 2 |
Why NCT00069732 stopped before completion
NCT00069732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 2 interventions - of which qigong is the first listed.
NCT00069732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00069732 about?
NCT00069732 is a clinical study titled "Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss". The goal of this study is to pilot test in a group of overweight-obese individuals the feasibility and acceptability and indications of efficacy of two CAM treatments, qigong, and acupressure-TAT, for improving long term maintenance of weight loss.
What is the current status of trial NCT00069732?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 90 participants.
What interventions are being tested in trial NCT00069732?
The interventions under investigation include: qigong (BEHAVIORAL), acupressure-TAT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00069732?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00069732's enrollment target sits among peer trials
90 772nd of 2000 higher than 1,199 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery